Effects of thyroid hormone analogue and a leukotrienes pathway-blocker on renal ischemia/reperfusion injury in mice

BMC Nephrology

Volumn 12, Issue 1, 2011, Pages

  Hadi, Najah R ^a   Al Amran, Fadhil G ^a   Hussein, Ayad A ^a  

^a UNIVERSITY OF KUFA   (Iraq)

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 3, 5 DIIODOTHYROPROPIONIC ACID; CREATININE; GLUTATHIONE; INTERLEUKIN 6; MALONALDEHYDE; PARATHYROID HORMONE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UREA; 3,5 DIIODOTHYROPROPIONIC ACID; 3,5-DIIODOTHYROPROPIONIC ACID; CYTOKINE; DIIODOTHYRONINE; INDOLE DERIVATIVE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; PROPIONIC ACID DERIVATIVE; THYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; HISTOPATHOLOGY; KIDNEY; KIDNEY FUNCTION; KIDNEY ISCHEMIA; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; REPERFUSION INJURY; ANIMAL; BLOOD; DRUG EFFECT; PATHOLOGY; PATHOPHYSIOLOGY; TREATMENT OUTCOME; VASCULARIZATION;

ANIMALS; CYTOKINES; DIIODOTHYRONINES; INDOLES; KIDNEY; LEUKOTRIENE ANTAGONISTS; LIPOXYGENASE INHIBITORS; MALE; MICE; PROPIONIC ACIDS; REPERFUSION INJURY; THYROID HORMONES; TREATMENT OUTCOME;

EID: 84155173349     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-12-70     Document Type: Article

References (68)

1. Epidemiology of acute kidney injury: how big is the problem? Hoste EA, Schurgers M, Crit Care Med 2008 36 146 S151 10.1097/CCM.0b013e318168c590 18382186 (Pubitemid 351483044)
2. Hypoxia induces endothelial cells to increase their adherence for neutrophils: role of PAF. Milhoan KA, Lane TA, Bloor CM, Am J Physiol 1992 263 956 H962 1415623
3. Role of neutrophils in ischemic heart disease: pathophysiologic role in myocardial ischemia and coronary artery reperfusion. Lucchesi BR, Cardiovasc Clin 1987 18 35 48 3038324 (Pubitemid 17109565)
4. Thromboxane mediates diapedesis after ischemia by activation of neutrophil adhesion receptors interacting with basally expressed intercellular adhesion molecule-1. Goldman G, Welbourn R, Klausner JM, Valeri CR, Shepro D, Hechtman HB, Circ Res 1991 68 1013 1019 1672629
5. P-selectin and ICAM-1-dependent adherence reactions: role in the genesis of postischemic no-reflow. Jerome SN, Dore M, Paulson JC, Smith CW, Korthuis RJ, Am J Physiol 1994 266 1316 H1321 7514358
6. Thromboxane mediates the ischemia -induced neutrophil oxidative burst. Paterson IS, Klausner JM, Goldman G, Kobzik L, Welbourn R, Valeri CR, et al. Surgery 1989 106 224 229 2527418 (Pubitemid 19236463)
7. Myocardial ischemia, reperfusion, and free radical injury. Lucchesi BR, Am J Cardiol 1990 65 141 231
8. Ischemic acute renal failure: an inflammatory disease? Bonventre JV, Zuk A, Kidney Int 2004 66 480 485 10.1111/j.1523-1755.2004.761-2.x 15253693 (Pubitemid 38981982)
9. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. Takada M, Nadeau KC, Shaw GD, Marquette KA, Tilney NL, J Clin Invest 1997 99 2682 2690 10.1172/JCI119457 9169498 (Pubitemid 27259815)
10. Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Donnahoo KK, Meng X, Ayala A, Cain MP, Harken AH, Meldrum DR, Am J Physiol 1999 277 922 R929 10484513
11. Ischemia/reperfusion-induced IFN-gamma up-regulation: Involvement of IL-12 and IL-18. Daemen MA, van't Veer C, Wolfs TG, Buurman WA, J Immunol 1999 162 5506 5510 10228031 (Pubitemid 29307162)
12. Acute renal failure after whole body ischemia is characterized by inflammation and T cell mediated injury. Kofler J, Yokota N, Weisfeldt M, Traystman RJ, Rabb H, Am J Physiol: Renal Physiol 2003 285 87 F94
13. Early renal ischemia, with or without reperfusion, activates NFB and increases TNF- bioactivity in the kidney. Donnahoo KK, Meldrum DR, Shenkar R, Chung C, Abraham E, Harken AH, J Urol 2000 163 1328 1332 10.1016/S0022-5347(05) 67772-5 10737538 (Pubitemid 30169434)
14. Role of tumor necrosis factor in renal ischemia and reperfusion injury (Review). Donnahoo KK, Shames BD, Harken AH, Meldrum DR, J Urol 1999 162 196 203 10.1097/00005392-199907000-00068 10379787 (Pubitemid 29420927)
15. Comparison of tumor necrosis factor-alpha effect on the expression of iNOS in macro and cardiac myocytes. Sanders DB, Larson DF, Hunter K, Gorman M, Yang B, Perfusion 2001 16 67 74 10.1177/026765910101600i110 11334210 (Pubitemid 32042190)
16. Location of an inducible nitric oxide synthase mRNA in the normal kidney. Morrissey JJ, McCracken R, Kaneto H, Yang B, Montani D, Klahr S, Kidney Int 1994 45 998 1005 10.1038/ki.1994.135 7516453 (Pubitemid 24234716)
17. Inhibition of inducibile nitric oxide synthase reduces renal ischemia/reperfusion injury. Chatterjee PK, Patel NSA, Kvale EO, Kidney Int 2002 61 862 871 10.1046/j.1523-1755.2002.00234.x 11849439 (Pubitemid 34175453)
18. Nitric oxide and nitric oxide synthase in the kidney: Potential roles in normal renal function and in renal dysfunction. Hill-Kapturczak N, Kapturczak MH, Malinski T, Gross P, Endothelium 1995 3 253 299 10.3109/10623329509024671 (Pubitemid 26022120)
19. Leukocytes, cell adhesion molecules and ischemic acute renal failure. Rabb H, O'Meara YM, Maderna P, Coleman P, Brady HR, Kidney Int 1997 51 1463 1468 10.1038/ki.1997.200 9150459 (Pubitemid 27239898)
20. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Dahlen SE, Bjork J, Hedqvist P, Arfors KE, Hammarstrom S, Lindgren JA, et al. Proc Natl Acad Sci USA 1981 78 3887 3891 10.1073/pnas.78.6.3887 6267608 (Pubitemid 11060581)
21. An in vivo approach showing the chemotactic activity of leukotriene B4 in acute renal ischemic-reperfusion injury. Noiri E, Yokomizo T, Nakao A, Izumi T, Fujita T, Kimura S, et al. Proc Natl Acad Sci USA 2000 97 823 828 10.1073/pnas.97.2.823 10639164 (Pubitemid 30070394)
22. Production of free radicals and lipid peroxides in early experimental myocardial ischemia. Rao PS, Cohen MV, Mueller HS, J Mol Cell Cardiol 1983 15 713 716 10.1016/0022-2828(83)90260-2 6315960 (Pubitemid 13019802)
23. Phospholipase A2 dependent release of fatty acids from peroxidized membranes. Sevanian A, Kim E, J Free Radic Biol Med 1985 1 263 271 10.1016/0748-5514(85)90130-8 3836246 (Pubitemid 16117020)
24. FLAP: a novel drug target for inhibiting the synthesis of leukotrienes. Ford-Hutchinson AW, Trends Pharmacol Sci 1991 12 68 70 2024291
25. Biochemical activity, pharmacokinetics, and tolerability of MK-886, a leukotriene biosynthesisinhibitor, in humans. Depre M, Friedman B, Tanaka W, Van Hecken A, Buntinx A, DeSchepper PJ, Clin Pharmacol Ther 1993 53 602 607 10.1038/clpt.1993.76 8387904 (Pubitemid 23161209)
26. Pharmacology of MK-0591 (3-[l-(4-chlorobenzyl)-3-(t-butylthio)-5- (quinolin-2-yl-methoxy)-indol-2-yl]-2, 2-dimethylpropanoic acid), a potent, orally active leukotriene biosynthesis inhibitor. Brideau C, Chan C, Charleson S, et al. Can J Physiol Pharmacol 1992 70 799 807 10.1139/y92-107 1330258
27. Effect of Montelukast and MK-886 on Hepatic Ischemia-Reperfusion Injury in Rats. Daglar G, Karaca T, Yuksek YN, Gozalan U, Akbiyik F, Sokmensuer C, et al. Journal of surgical research 2009 153 1 31 38 10.1016/j.jss.2008.02.052 18656901
28. Montelukast protects against renal ischemia/reperfusion injury in rats. ener G, ehirli Veliolu-ünç A, etinel S, Gedik N, Caner M, Sakarcan A, et al. Pharm Rese 2006 54 1 65 71 10.1016/j.phrs.2006.02.007 (Pubitemid 43850825)
29. Thyroid hormone and phenotypes of cardioprotection. Pantos C, Malliopoulou V, Varonos D, Cokkinos DV, Basic Res Cardiol 2004 99 101 120 10.1007/s00395-003-0449-0 14963669 (Pubitemid 38325024)
30. Triiodothyronine improves left ventricular function without oxygen wasting effects after global hypothermic ischaemia. Klemperer JD, Zelano J, Helm RE, Berman K, Ojamaa K, Klein I, et al. J Thorac Cardiovasc Surg 1995 109 3 457 465 10.1016/S0022-5223(95)70276-8 7877306
31. Acute effects of triiodothyronine on glucose and fatty acid metabolism during reperfusion of ischaemic rat hearts. Liu Q, Clanachan AS, Lopaschuk GD, Am J Physiol 1998 275 3 392 E399 9725804
32. Postischaemic recovery of mechanical performance and energy metabolism in the presence of left ventricular hypertrophy: a 31P-MRS study. Buser PT, Wikman-Coffelt J, Wu ST, Derugin N, Parmley WW, Higgins CB, Circ Res 1990 66 3 735 746 2137728 (Pubitemid 20086911)
33. Long-term thyroxine administration protects the heart in a similar pattern as ischaemic preconditioning. Pantos C, Malliopoulou V, Mourouzis I, Karamanoli E, Paizis I, Steimberg N, et al. Thyroid 2002 12 325 329 10.1089/10507250252949469 12034058 (Pubitemid 34438937)
34. Myocardial ischemia-basic concepts, stress signalling in myocardial ischemia. Pantos C, Mourouzis I, Cokkinos DV, Myocardial Ischemia; from Mechanisms to Therapeutic Potentials, Springer, New York, NY 10013, USA, Cokkinos DV, Pantos C, Heusch G, Taegtmeyer H, 2006 29 52
35. Thyroid hormone analogs for treatment of hypercholesterolemia and heart failure: past, present and future prospects. Morkin E, Ladenson P, Goldman S, Adamson C, J Mol Cell Cardiol 2004 37 1137 1146 15572044 (Pubitemid 39585161)
36. Proangiogenesis action of the thyroid hormone analog 3, 5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated. Mousa SA, O'Connor L, Davis FB, Davis PJ, Endocrinology 2006 147 1602 1607 16384862
37. Clinical and experimental studies on the use of 3, 5-diiodothyropropionic acid, a thyroid hormone analogue, in heart failure. Morkin E, Pennock GD, Spooner PH, Bahl JJ, Goldman S, Thyroid 2002 12 6 527 533 10.1089/ 105072502760143935 12165118 (Pubitemid 34721552)
38. Prevention of Abnormal Sarcoplasmic Reticulum Calcium Transport and Protein Expression in Post-infarction Heart Failure Using 3, 5-Diiodothyropropionic Acid (DITPA). Pennock GD, Spooner PH, Summers CE, Litwin SE, 2000 32 11 1939 1953
39. The 5-Lipoxygenase Pathway Meditates Acute Lung Injury Following Hemorrhagic Shock. Eun JC, Moore EE, Mauchley DC, Meng X, Banerjee A, Journal of Surgical Research 2010 158 2 215 216
40. Regulation of Gene Expression in Rats With Heart Failure Treated With the Thyroid Hormone Analog 3, 5-Diiodothyropropionic Acid (DITPA) and the Combination of DITPA and Captopril. Niranjan M, Cynthia A, Kevin G, Scott K, James H, Joseph JB, Journal of cardiovascularPharmacology 2007 50 5 526 534
41. Inhibition of COX 1 and 2 prior to Renal Ischemia/Reperfusion Injury Decreases the Development of Fibrosis. Feitoza CQ, Gonçalves GM, Semedo P, Cenedeze MA, Pinheiro H, Beraldo FC, mol med 2008 14 11-12 724 730 18769637
42. Amelioration of Renal Ischemia-Reperfusion Injury by Inhibitionof IL-6 Production in the Poloxamer 407-Induced Mouse Modelof Hyperlipidemia. Sharyo S, Kumagai K, Yokota-Ikeda N, Ito K, Ikeda M, J Pharmacol Sci 2009 110 47 54 10.1254/jphs.08283FP 19403996
43. Which is more effective in the prevention of renal ischemia-reperfusion- induced oxidative injury in the early period in mice: interleukin (IL)-10 or anti-IL-12? Köken T, Serteser M, Kahraman A, Akbulut G, Dilek ON, Clin Biochem 2004 37 1 50 55 10.1016/j.clinbiochem.2003.10.001 14675562 (Pubitemid 37522125)
44. Microsomal lipid peroxidation. Beuge JA, Aust SD, Meth Enzymol 1978 52 302 311 672633
45. JTE-607, an Inflammatory Cytokine Synthesis Inhibitor, Attenuates Ischemia/Reperfusion-Induced Renal Injury by Reducing Neutrophil Activation in Rats. Asaga T, Ueki M, Chujo K, Taie S, J Bio sci Bio eng 2008 106 1 22 26
46. Expression of interleukin 6 and major histocompatibility complex molecules in tubular epithelial cells of diseased human kidneys. Fukatsu A, Matsuo S, Yuzawa Y, Miyai H, Futenma A, Kato K, Lab Investig 1993 69 58 67 8331900 (Pubitemid 23222247)
47. Interleukin-18. Gracie JA, Robertson SE, McInnes IB, J Leukoc Biol 2003 73 213 224 10.1189/jlb.0602313 12554798 (Pubitemid 36158296)
48. The role of TNF- in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. Popa C, Netea MG, J Lipid Res 2007 48 751 762 10.1194/jlr.R600021-JLR200 17202130 (Pubitemid 46557880)
49. Neutrophils and acute ischemia-reperfusion injury. De Greef KE, Ysebaert DK, Ghielli M, Vercauteren S, Nouwen EJ, Eyskens EJ, et al. J Nephrol 1998 11 110 122 9650119 (Pubitemid 28288216)
50. Maladaptive Role of IL-6 in Ischemic Acute Renal Failure. Kielar ML, John R, Bennett M, Richardson JA, Shelton JM, Chen L, et al. J Am Soc Nephrol 2005 16 3315 3325 10.1681/ASN.2003090757 16192425 (Pubitemid 46179335)
51. Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone. Mejía-Vilet JM, Ramírez V, Cruz C, Uribe N, Gamba G, Bobadilla NA, Am J Physiol Renal Physiol 2007 293 78 F86
52. Wen-pi-tang-Hab-Wu-ling-san attenuates kidneyischemia/reperfusion injury in mice A role for antioxidant enzymes and heat-shock proteins. Seok YM, Kima J, Choi KC, Yoon CH, Boob YC, Park Y, et al. Journal of Ethnopharmacology 2007 112 333 340 10.1016/j.jep.2007.03.015 17446018 (Pubitemid 46778960)
53. Antioxidant defense and free radical production in a rabbit model of kidney ischemia reperfusion. Fransen C, Defraigne JO, Detry O, Pincemail J, Deby C, Lamy M, Transplant Proc 1995 27 2880 2883 7482954
54. Assessment of myocardial oxidative stress in patients after myocardial revascularization. Ferreira R, Llesuy S, Milei J, Scordo D, Hourquebie H, Molteni L, et al. Am Heart J 1988 115 307 312 231 10.1016/0002-8703(88)90475-9 3341166 (Pubitemid 18043275)
55. The evaluation of lipid peroxidation and adensine Deaminase activity in patient with Behcehs disease. Kose K, Yazici C, & Assioglu O, Clin Bio Chem 2001 34 2 125 9 (Pubitemid 32322704)
56. Glutathion. Meister A, Anderson M, Annu Rev Biol Chem 1988 52 711 60
57. Studies of urea excretion. II. Relationship between urine volume and the rate of urea excretion by normal adults. Möller E, McIntosh JF, Van Slyke DD, J Clin Invest 1929 6 427
58. Necrosis and apoptosis in acute renal failure. Lieberthal W, Koh JS, Levine JS, Semin Nephrol 1998 18 505 518 9754603 (Pubitemid 28430754)
59. Activation of the 5-lipoxygenase pathway of arachidonic acid metabolism. Ford-Hutchinson AW, Pharmacology of the Respiratory Tract:Experimental and clinical Research. New York, USA.Marcel Dekker, Chung KF, Barnes PJ, 1993 375 414
60. 4up-regulates IL-6 rather than IL-1 synthesis in human monocytes. Poubelle PE, Stankova J, Grassi J, Rola-Pleszczynski M, inflamm resea 1993 34 1-2 42 45
61. Leukotriene B4 enhances interleukin-6 (IL-6) production and IL-6 messenger RNA accumulation in human monocytes in vitro: transcriptional and posttranscriptional mechanisms. Rola-Pleszczynski M, Stankova J, Blood 1992 80 4 1004 11 1323342
62. The interplay between primary and secondary cytokines: cytokines involved in the regulation of monocyte recruitment. Mantovani A, Drugs 1997 54 Suppl 1 15 23 9378074 (Pubitemid 27417393)
63. IL-18 Enhances Collagen-Induced Arthritis by Recruiting Neutrophils Via TNF- and Leukotriene B4. Cannetti CA, Leung BP, Culshaw S, McInnes IB, Cunha FQ, Liew FY, J Immunol 2003 171 1009 1015 12847274 (Pubitemid 36871417)
64. 15-epi-16-(para-Fluorophenoxy)-lipoxin A4-methyl ester, a synthetic analogue of 15-epi-lipoxin A4, is protective in experimental ischemic acute renal failure. Leonard MO, Hannan K, Burne MJ, Lappin DW, Doran P, Coleman P, et al. J Am Soc Nephrol 2002 13 1657 1662 10.1097/01.ASN.0000015795.74094.91 12039996 (Pubitemid 34579255)
65. Inhibitors of poly (ADP-ribose) synthetase reduce renal ischemia-reperfusion injury in the anesthetized rat in vivo. Chatterjee PK, Zacharowski K, Cuzzocrea S, Otto M, Thiemermann C, FASEB J 2000 14 641 651 10744621 (Pubitemid 30198563)
66. Membrane receptors mediating thyroid hormone action. Davis PJ, Davis FB, Cody V, Trends Endocrinol Metab 2005 16 429 435 10.1016/j.tem.2005.09.007 16214361 (Pubitemid 41506950)
67. Thyroid hormone preconditioning: protection against ischemia-reperfusion liver injury in the rat. Fernández V, Castillo I, Tapia G, Romanque P, Uribe-Echevarría S, Uribe M, et al. Hepatology 2007 45 1 170 7 10.1002/hep.21476 17187421 (Pubitemid 46144376)
68. Heme oxygenase-1 is induced by Thyroid hormone and involved in thyroid hormone preconditioning-induced protection against renal warm ischemia in rat. Li F, Lu S, Zhu R, Zhou Z, Ma L, Cai L, et al. Mol Cell Endocrinol () 2011 PMID 21458530